Henan Xu

1.1k total citations
24 papers, 779 citations indexed

About

Henan Xu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Henan Xu has authored 24 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Henan Xu's work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (5 papers). Henan Xu is often cited by papers focused on MicroRNA in disease regulation (6 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (5 papers). Henan Xu collaborates with scholars based in China and Japan. Henan Xu's co-authors include Xuetao Cao, Wenrui Wang, Qingling Yang, Sulian Chen, Lei Yan, Changjie Chen, Panpan Li, Lun Liu, Zhike Lu and Yang Jiang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Henan Xu

23 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henan Xu China 14 501 318 98 85 84 24 779
Chang Bao China 13 587 1.2× 346 1.1× 53 0.5× 111 1.3× 101 1.2× 17 993
Anowar Hussain India 11 337 0.7× 239 0.8× 43 0.4× 85 1.0× 135 1.6× 18 658
Qiuyue Hu China 19 684 1.4× 289 0.9× 151 1.5× 73 0.9× 122 1.5× 50 1.1k
Chinmayee Sethy India 16 473 0.9× 129 0.4× 103 1.1× 122 1.4× 116 1.4× 24 923
Li-Chun Cheng China 10 347 0.7× 160 0.5× 144 1.5× 98 1.2× 84 1.0× 12 600
Aditya Parekh India 12 418 0.8× 205 0.6× 58 0.6× 108 1.3× 64 0.8× 21 738
Qian Wen China 19 321 0.6× 135 0.4× 49 0.5× 216 2.5× 183 2.2× 42 837
Jingbin� Huang China 14 361 0.7× 101 0.3× 55 0.6× 106 1.2× 70 0.8× 34 627
Qin He China 14 425 0.8× 219 0.7× 71 0.7× 110 1.3× 168 2.0× 21 734
Dong‐Sheng Huang China 13 317 0.6× 140 0.4× 66 0.7× 120 1.4× 82 1.0× 31 671

Countries citing papers authored by Henan Xu

Since Specialization
Citations

This map shows the geographic impact of Henan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henan Xu more than expected).

Fields of papers citing papers by Henan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henan Xu. The network helps show where Henan Xu may publish in the future.

Co-authorship network of co-authors of Henan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Henan Xu. A scholar is included among the top collaborators of Henan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henan Xu. Henan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Deyu, Bo Li, Henan Xu, et al.. (2024). Identification of FBLL1 as a neuron-specific RNA 2′-O-methyltransferase mediating neuronal differentiation. Proceedings of the National Academy of Sciences. 121(48). e2406961121–e2406961121. 2 indexed citations
3.
Wang, Xin, Yangyang Chai, Quan Yuan, et al.. (2024). NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression. Journal of Hematology & Oncology. 17(1). 97–97. 11 indexed citations
4.
Xu, Henan, Xiao Zhang, Bo Li, et al.. (2024). Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity. Immunity. 57(8). 1796–1811.e8. 29 indexed citations
5.
Xu, Henan, Lingling Zhang, Huilin Wang, et al.. (2023). Ball-milling Synthesis of Single-atom Cu Anchored on N-Doped Carbon for Mimicking Peroxidase. Chemical Research in Chinese Universities. 39(6). 948–953. 6 indexed citations
6.
Jiang, Yan, Siqi Sun, Quan Yuan, et al.. (2023). Nuclear RPSA senses viral nucleic acids to promote the innate inflammatory response. Nature Communications. 14(1). 8455–8455. 15 indexed citations
7.
Jiang, Wei, Xinyu Li, Henan Xu, et al.. (2023). UBL7 enhances antiviral innate immunity by promoting Lys27-linked polyubiquitination of MAVS. Cell Reports. 42(3). 112272–112272. 6 indexed citations
8.
Wang, Lijuan, et al.. (2022). Activation of cancer immunotherapy by nanomedicine. Frontiers in Pharmacology. 13. 1041073–1041073. 10 indexed citations
9.
Zhang, Lingyu, Henan Xu, Lei Yan, et al.. (2021). MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer. Pathology - Research and Practice. 220. 153405–153405. 31 indexed citations
10.
Wang, Haifeng, Lei Yan, Shuo Yang, et al.. (2020). The N‐terminal polypeptide derived from vMIP‐II exerts its antitumor activity in human breast cancer through CXCR4/miR‐7‐5p/Skp2 pathway. Journal of Cellular Physiology. 235(12). 9474–9486. 8 indexed citations
11.
Liu, Yang, Zhike Lu, Yang Jiang, et al.. (2019). N 6 -methyladenosine RNA modification–mediated cellular metabolism rewiring inhibits viral replication. Science. 365(6458). 1171–1176. 171 indexed citations
12.
Xu, Henan, Yan Jiang, Xiaoqing Xu, et al.. (2019). Inducible degradation of lncRNA Sros1 promotes IFN-γ-mediated activation of innate immune responses by stabilizing Stat1 mRNA. Nature Immunology. 20(12). 1621–1630. 95 indexed citations
13.
Zhang, Lingyu, Tiantian Chen, Lei Yan, et al.. (2019). MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer. Gene. 700. 85–95. 33 indexed citations
14.
Yan, Lei, Shuo Yang, Henan Xu, et al.. (2019). Long noncoding RNA AC073284.4 suppresses epithelial–mesenchymal transition by sponging miR‐18b‐5p in paclitaxel‐resistant breast cancer cells. Journal of Cellular Physiology. 234(12). 23202–23215. 40 indexed citations
15.
Li, Kaili, Henan Xu, Wei Jiang, et al.. (2018). Development and characterization of stable reporter cells for fast and sensitive detection of pyrogen. Analytical Biochemistry. 557. 69–76. 2 indexed citations
16.
Wang, Yueyue, Lei Yan, Lingyu Zhang, et al.. (2018). NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer. International Journal of Oncology. 53(3). 1043–1054. 14 indexed citations
17.
Zhang, Yuzhe, et al.. (2017). Synthesis of isoamoxyphthalocyanine-attapulgite composites and its efficient photocatalytic degradation of malachite green under visible-light irradiation. Journal of Materials Science Materials in Electronics. 29(5). 3876–3883. 4 indexed citations
18.
19.
Xu, Jia, Xiaoqing Xu, Bingjing Wang, et al.. (2017). Nuclear carbonic anhydrase 6B associates with PRMT5 to epigenetically promote IL-12 expression in innate response. Proceedings of the National Academy of Sciences. 114(32). 8620–8625. 21 indexed citations
20.
Xu, Henan, Haijun Chen, Biyuan Zheng, et al.. (2014). Preparation and sonodynamic activities of water-soluble tetra-α-(3-carboxyphenoxyl) zinc(II) phthalocyanine and its bovine serum albumin conjugate. Ultrasonics Sonochemistry. 22. 125–131. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026